Showing results (31-40 of 89) with videos related to
Sort By:
Pageof 9
Bioconjugate Chemistry|December 5, 2008
A new PEG-beta-alanine active derivative for releasable protein conjugationGianfranco Pasut, Anna Mero, Francesca Caboi, et al.Current Drug Targets|January 8, 2015
Hyaluronic Acid as a Protein Polymeric Carrier: An Overview and a Report on Human Growth HormoneAnna Mero, Monica Campisi, Michele Caputo, et al.Acta Cirurgica Brasileira|March 12, 2020
Original and generic preservation solutions in organ transplantation. A new paradigm?Joan Roselló-Catafau, Arnau Panisello-Roselló, Gianfranco Pasut, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|March 19, 2008
Antitumoral activity of PEG-gemcitabine prodrugs targeted by folic acidGianfranco Pasut, Fabiana Canal, Lisa Dalla Via, et al.Biomacromolecules|August 28, 2023
Improving the Therapeutic Potential of G-CSF through Compact Circular PEGylation Based on Orthogonal ConjugationsAntonella Grigoletto, Valentina Marotti, Tommaso Tedeschini, et al.Pharmaceutics|July 2, 2021
Folic Acid-Targeted Paclitaxel-Polymer Conjugates Exert Selective Cytotoxicity and Modulate Invasiveness of Colon Cancer CellsAntonella Grigoletto, Gabriele Martinez, Daniela Gabbia, et al.Pharmaceutical Research|June 5, 2025
PEGylation of Propofol Reduces Its Adsorption to Extracorporeal Membrane Oxygenator (ECMO) ComponentsBenedetta Campara, Nitish Khurana, Andrea De Nadai, et al.European Journal of Medicinal Chemistry|August 23, 2003
Synthesis, characterization and preliminary cytotoxicity assays of poly(ethylene glycol)-malonato-Pt-DACH conjugatesAlessia Furin, Andrea Guiotto, Franca Baccichetti, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 4, 2006
Nitric oxide modulates proapoptotic and antiapoptotic properties of chemotherapy agents: the case of NO-pegylated epirubicinLuca Santucci, Andrea Mencarelli, Barbara Renga, et al.Anti-Cancer Agents in Medicinal Chemistry|August 20, 2016
Thiol-Activated Anticancer Agents: The State of the ArtDaniele Dalzoppo, Veronica Di Paolo, Laura Calderan, et al.Pageof 9